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Experiments were performed to determine whether visna/maedi virus (VMV), a small ruminant
lentivirus (SRLV), could infect sheep via ocular tissues. The EV1 strain of VMV was administered
into the conjunctival space of uninfected sheep, and the animals monitored for the presence of
provirus DNA and anti-VMV antibodies in blood. The results showed that provirus DNA appeared
in peripheral blood mononuclear cells of all animals within a few weeks of receiving either 106
TCID50 or 10
3 TCID50 of VMV. Of the animals receiving the higher dose of virus via the
conjunctival space, two seroconverted by 7 and 10 weeks post-infection, one seroconverted
8 months post-infection, and one had not seroconverted by 15 months post-infection. With the
lower virus dose, the animals infected via the trachea seroconverted by 4 and 14 weeks,
respectively. After ocular infection with this dose, one animal showed a transitory seroconversion
with low levels of antibody, peaking at 2 weeks post-administration. The remaining three of the
animals infected via the eyes did not seroconvert over a period of 13 months. At post-mortem,
evidence for the presence of proviral DNA was obtained from ocular tissue, lungs or mediastinal
lymph node in both groups of animals. Histological analysis of lung tissue from animals receiving
the lower dose of virus showed the presence of early inflammatory lesions. The results thus
show for the first time that transmission of VMV can occur via ocular tissues, suggesting that the
conjunctival space may be an additional route of natural transmission.
INTRODUCTION
Visna/maedi virus (VMV) and caprine arthritis enceph-
alitis virus (CAEV) are small ruminant lentiviruses (SRLV)
that cause chronic progressive inflammatory disease in the
lungs, brain, joints and mammary glands of sheep and
goats (Haase, 1986). Lymphoid tissue hyperplasia is also a
feature, and more rarely lesions can be found in other
tissues such as the kidneys, liver and heart (Georgsson &
Palsson, 1971; Brellou et al., 2007). Recently, evidence for
involvement of ocular tissues has been provided in natural
cases of VMV infection (Capucchio et al., 2003).
The SRLV show a distinct tropism for cells of the monocyte-
macrophage lineage and hence target organs rich in these cell
types (Narayan et al., 1982; Gendelman et al., 1986). The
main routes of infection are thought to be ingestion of
colostrum or milk containing infected macrophages and/or
free virus or via contact with respiratory aerosols (Cutlip
et al., 1985; Adams et al., 1983; van der Molen & Houwers,
1987; Palsson, 1976). It is known that alveolar macrophages
are a target for infection (Gendelman et al., 1986) and it has
been recently demonstrated that lung fluid from naturally
infected sheep contains free virus at levels commensurate
with efficient transmission via contact with respiratory
secretions (McNeilly et al., 2007). It has also been shown that
infection via the distal lung tissues is very efficient compared
with tracheal (McNeilly et al., 2007) or nasal tissues
(Torsteinsdo´ttir et al., 2003). The available information
thus points to transmission between adult animals occurring
through inhalation of aerosolized free virus and possibly
aerosolized alveolar macrophages and subsequent infection
of recipient alveolar macrophages or respiratory tract
dendritic cells (Pepin et al., 1998).
The observation that ocular tissues may be a natural target
for infection (Capucchio et al., 2003) indicates that
appropriate target cells for VMV reside in eye tissues.
Virus antigen was found in the third eyelid, a structure that
is contiguous with conjunctival tissue (Baba et al., 1995).
Indeed, conjunctiva-associated lymphoid tissue (CALT)
has been described in many species (Baba et al., 1995; Knop
& Knop, 2005). CALT patches have been shown to contain
lymphocytes, M cells, dendritic cells and lymphoid follicles
with germinal centres (Kageyama et al., 2006). Given that
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aerosolized lung fluid could contain free virus, it is
conceivable that infection may occur through ocular contact
of such infected fluid with CALT patches in either
conjunctival tissue or the third eyelid by aerosol droplets
or through eye licking. However, the eyes possess natural
defence mechanisms which could limit infection through
this route. For example, the production of lysozyme,
proteases, defensins and other components of innate
defences act to provide a barrier to pathogens (Streilein,
1999). Constant drainage of ocular extracellular fluid into
the nasal passages also serves to clear the eyes of potential
infectious agents. Despite this, it has been shown that many
virus infections can occur via ocular tissues either naturally,
experimentally or iatrogenically. Examples include adeno-
virus (Bell et al., 1956), measles virus (Rozina et al., 1988),
cytomegalovirus (Zhang et al., 2007), herpes simplex virus 1
(Orlando et al., 2006; Robert et al., 2005) and Ebola virus
(Jaax et al., 1996). Recent data also raise the possibility that
avian influenza virus H7N7 and adenovirus 37 may gain
access via ocular tissues (Olofsson et al., 2005).
In this report, we have investigated whether the lentivirus
VMV can infect sheep via the conjunctival space. We have
used the tracheal route of infection as a known efficient
route of infection as a control, and tested two doses of virus
to assess the efficiency of ocular infection in sheep.
METHODS
Virus propagation and titration. Low-passage VMV strain EV1
(Sargan et al., 1991) was propagated routinely on ovine skin fibroblast
cells (OSCs) in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal calf serum (FCS). Virus-containing
culture medium was clarified by centrifugation for 10 min at 400 g
and subsequently filtered through a 0.2 mm syringe-driven filter
(Nalgene). Tissue culture medium from uninfected OSCs was used as
a negative control. Virus titres were determined as described
previously using OSCs as indicator cells (Ebrahimi et al., 2000).
Titres were expressed as tissue culture infectious dose 50% (TCID50).
Isolation of peripheral blood mononuclear cells (PBMCs). Blood
was collected into an EDTA-containing Vacutainer (Becton Dickenson)
and PBMCs were isolated using a Ficoll-Paque density gradient (GE
Healthcare) according to the manufacturer’s instructions. Cells were
pelleted by centrifugation at 100 g for 10 min and the resultant cell
pellet was resuspended in 200 ml phosphate buffered saline. DNA was
subsequently extracted using a DNeasy mini kit (Qiagen).
Detection of VMV provirus. VMV provirus was detected by semi-
nested PCR (snPCR) using the first-round primer pair gag 1 and gag 5
and second-round primer pair gag 1 and gag 2 to give a 463 bp
product as described previously (McNeilly et al., 2007). The detection
threshold of the snPCR was 50 plasmid copies/reaction.
Detection of VMV-specific serum antibodies. Serum samples
diluted 100-fold were tested for the presence of virus-specific
antibodies to the major core protein p25 of VMV and/or the viral
transmembrane protein gp46 using a commercial ELISA kit
(ELITEST-MVV/CAEV; Hyphen BioMed) (Saman et al., 1999).
Absorbance values were measured using a BioTek Microplate
Autoreader (BioTek Instruments). Based on pre-infection values, an
arbitrary cut-off of 0.1 optical density values was used to determine
positive and negative reactions.
Sheep and experimental design. Fifteen Blackface or Blackface cross
ewes aged between 18 months and 2 years were used for the
experimental infection studies. All sheep were commercially sourced.
Prior to VMV infection studies, sheep were determined to be free from
VMV proviral DNA using snPCR, and seronegative for VMV-specific
antibodies using ELISA. All experimental procedures involving animals
were approved by The University of Edinburgh’s Biological Services
Ethical Review Committee and were performed under licence as
required by the UK Animals (Scientific procedures) Act 1986.
Six sheep received a 106 TCID50 dose of the EV1 strain of VMV; a
second group of six sheep received a 103 TCID50 dose of EV1. Two
animals in each group received VMV via the trachea. The four
remaining animals in each group received virus via the conjunctival
space. One negative control sheep (C1) received uninfected tissue
culture medium in the same manner via the conjunctival space. Blood
samples were taken at regular intervals over a period of several weeks
or months for measurement of VMV provirus and anti-VMV
antibodies. A further two sheep (C2 and C3) were untreated and
were used as negative controls in the post-mortem studies.
Intra-tracheal and ocular inoculation of VMV. Sheep were sedated
by intramuscular injection of xylazine hydrochloride (Rompun;
Bayer) at a dose rate of approximately 0.5 mg kg–1. One millilitre
volumes of cell-free virus (106 TCID50) were injected into the
proximal third of the trachea via a 21 gauge needle, avoiding the
tracheal cartilage. The neck was held in dorsiflexion for 1–2 min post-
instillation. For ocular inoculation, sheep were similarly sedated and
500 ml of the same virus preparation or control medium was
introduced drop-wise into the conjunctival space of each eye over a
period of approximately two minutes.
Post-mortem provirus detection and histopathological ana-
lysis. Two sheep receiving the 106 TCID50 dose of virus intratrache-
ally (sheep 607c, 329c) or ocularly (sheep 405, 301) were killed 8
months post-infection and necropsied. The remaining two of the
sheep in this group (sheep 271 and 200) were blood sampled for a
further 7 months and necropsied at 15 months post-infection. All
sheep receiving the 103 TCID50 dose of virus were necropsied at 13
months post-infection. Two uninfected control sheep (C2, C3) were
also necropsied at the same time.
Bronchiolar lavage was performed as follows: a Luer-tipped 50 ml
syringe was wedged into selected segmental bronchi and a single
40 ml aliquot of normal saline was used to wash the lung segment.
Bronchiolar lavage samples were passed through sterile gauze into
sterile 50 ml Falcon tubes on ice and subsequently centrifuged at
400 g for 7 min at 4 uC to separate out the cellular fraction (BAL
cells). DNA was extracted from the BAL cells for snPCR analysis. The
following tissues were taken for DNA extraction and sectioning: left
cardiac lung lobes, right and left conjunctiva, and right and left third
eyelids. Tissue sections were stained with haematoxylin and eosin for
histopathological analysis. The degree of airways mononuclear cell
infiltration, interstitial pneumonia and lymph node follicular
reactivity were assessed and lesions were categorized as mild,
moderate or severe by an experienced pathologist.
RESULTS
Provirus in blood of experimentally infected
sheep
To determine whether sheep can be infected via the ocular
route, blood samples were taken at regular intervals after
experimental infection of sheep via the conjunctival space
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or the trachea and proviral DNA measured in PBMCs.
Positive snPCR reactions were first observed in sheep that
received 106 TCID50 via the trachea 2–4 weeks post-infection
(Table 1). In sheep that received 106 TCID50 VMV via the
conjunctival space, the animals first became positive by
snPCR at 4, 5 and 9 weeks post-infection. Thereafter,
positive reactions were found in all sheep over the following
22 weeks. All sheep tested gave intermittent negative
reactions on occasions, and the strength of the PCR band
obtained ranged from weak to strong in the same animal
over time. Representative examples of the snPCR results are
shown in Fig. 1. No reactions were observed in samples
taken prior to infection in either group (Fig. 1a, high-dose
group). The results obtained on week 15 post-infection with
106 TCID50 are shown in Fig. 1b. All sheep gave positive
bands, though the reactions obtained with sheep 301 and
sheep 200 at this time point were weak. A similar analysis
was performed on sheep infected with 103 TCID50. Again,
positive reactions were obtained from week 2 post-infection
in both sheep infected via the trachea and one of the sheep
infected via the eyes (Table 1). The other three animals of the
latter group became positive at 4 weeks post-infection.
Similar fluctuations in positivity and strength of reaction
were observed in this group of animals as was found in
animals that received the higher dose of virus. PBMCs from
control animal C1 were tested by snPCR on weeks 0, 2, 4, 6
and 7 post-inoculation with uninfected tissue culture
medium and were consistently negative (not shown).
The proportions of samples that were PCR positive are
shown in Table 1. For statistical purposes, the data from
animals infected via the conjunctival space (n58) were
pooled and compared with the pooled data from the sheep
infected via the trachea (n54) using the Mann–Whitney
rank test. The median and inter-quartile range for the
tracheal group was 64 and 48–79, while for the conjunctival
group it was 57 and 46–70. There was no significant
difference between the two routes of infection.
Seroconversion of experimentally infected sheep
To ascertain whether virus gene expression had taken place
in vivo after ocular infection, serum samples obtained from
the experimentally infected animals were analysed for
evidence of seroconversion by ELISA. The results are shown
in Figs 2 and 3 and Table 1. The animals infected via the
trachea with a virus dose of 106 TCID50 both seroconverted
by 2 weeks post-infection, and remained seropositive for the
period of sampling (sheep 607c and 329c) (Fig. 2). Similarly,
two animals that received this virus dose via the conjunctival
space also seroconverted, at 7 and 10 weeks post-infection,
respectively (sheep 405 and 301). Sheep 271 was negative
throughout the period of observation while sheep 200
showed delayed seroconversion, taking approximately 8
months for antibodies to appear.
The animals that were infected with 103 TCID50 dose via
the trachea seroconverted 4 and 14 weeks post-infection,
with sheep 297c showing very high levels of antibody while
sheep 361c had only low levels (Fig. 3). In contrast, only
one of four animals infected via the conjunctival space
seroconverted, as determined by ELISA, over the 13 month
Table 1. Summary of provirus detection in blood by PCR following tracheal or ocular infection with 106 TCID50 or 10
3 TCID50 EV1
strain of VMV
NR, Negative reaction; NSC, no seroconversion; p.i., post-infection.
Sheep number Inoculation route Time to become PCR
positive (weeks p.i.)
Number of samples PCR
positive/tested (%)*
Time to seroconversion
(weeks p.i.)
106 TCID50
607c Trachea 4 10/16 (63) 2
329c Trachea 2 11/17 (65) 2
405 Conjunctival space 9 10/18 (56) 7
271 Conjunctival space 4 12/18 (67) NSC
301 Conjunctival space 5 13/18 (72) 10
200 Conjunctival space 4 9/18 (50) 31
103 TCID50
297c Trachea 2 11/12 (92) 4
361c Trachea 2 4/12 (33) 14
299 Conjunctival space 4 7/12 (58) 2
236 Conjunctival space 4 4/12 (33) NSC
606 Conjunctival space 4 5/12 (42) NSC
686 Conjunctival space 2 9/12 (75) NSC
Negative control
C1 Conjunctival space NR 0/4 (0) NSC
*Over a period of 22 weeks post-challenge for sheep that received 106 TCID50 VMV, 12 weeks post-challenge for sheep that received 10
3 TCID50
VMV, and 7 weeks post-challenge with saline for control sheep C1. All sheep were negative pre-challenge.
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period of observation. The antibody response in this
animal (sheep 299) was low and transitory, peaking around
3 weeks post-infection (Fig. 3). We interpreted the
appearance of a ‘peak’ of antibody values above 0.1 OD
cut-off in sheep 361c and sheep 299 as evidence in favour
of a ‘real’ seroconversion. However, sheep 236, 606 and 686
did not show a pattern that could be convincingly
described as a ‘peak’ with values above 0.1 OD. Sera from
control animal C1 were tested by ELISA on weeks 0, 2, 4, 6
and 7, and were consistently negative (not shown).
There was no obvious correlation between the viral load as
measured by the number of successful PCR reactions and
the serological status of the animals.
Proviral DNA in tissues of experimentally infected
sheep
To determine whether VMV was present at and/or had
disseminated from the site of inoculation, tissues from the
eyes, lung, and mediastinal lymph node (MLN) were taken
at post-mortem and analysed for the presence of proviral
DNA by snPCR. All sheep gave positive PCR reactions in
blood samples taken immediately prior to post-mortem
(not shown). An analysis of proviral DNA in pulmonary
and ocular tissues was undertaken in both groups of sheep.
The results are shown in Table 2 and representative snPCR
gels are shown in Fig. 1c. In sheep infected with a 106
Fig. 1. Detection of VMV provirus DNA in peripheral blood
mononuclear cells (PBMC) or ocular tissues following infection
with EV1 strain of VMV. Sheep identification numbers are shown
above each track. Sheep 405, 301, 271 and 200 received virus into
the conjunctival space; sheep 329c and 607c received virus via the
trachea. The sizes of the molecular mass markers are given as
number of base pairs. (a) Provirus DNA in PBMC samples from
week 0 pre-infection with 106 TCID50 VMV. (b) Provirus DNA in
PBMC samples from week 15 post-infection with 106 TCID50 VMV.
(c) Provirus DNA in samples from left conjunctiva (sheep 607c) and
right third eyelid (sheep 405 and sheep 301) of sheep infected with
106 TCID50 VMV, and left conjunctiva of sheep 686 which was
infected with 103 TCID50 VMV.+, Positive; ”, negative.
Table 2. Summary of provirus detection in tissues by PCR following tracheal or ocular infection with 106 TCID50 or 10
3 TCID50 EV1
strain of VMV
RC, Right conjunctiva; LC, left conjunctiva; R3L, right third eyelid; L3L, left third eyelid; Lung, left cranial lung lobe; MLN, mediastinal lymph
node; BAL, bronchiolar lavage cells; UT, untreated.; ND, not done; +, positive by PCR; 2, negative by PCR; +/2, equivocal PCR reactions.
Sheep number* Inoculation route Tissue sampled
RC LC R3L L3L Lung MLN BAL
106 TCID50
607c Trachea 2 + 2 2 + ND ND
329c Trachea 2 + 2 2 2 ND ND
405 Conjunctival space + 2 + 2 2 ND ND
271 Conjunctival space +/2 +/2 2 +/2 +/2 2 ND
301 Conjunctival space 2 + + + + ND ND
200 Conjunctival space 2 2 2 2 2 +/2 ND
103 TCID50
297c Trachea 2 2 2 2 2 2 +
361c Trachea 2 2 2 2 2 2 2
299 Conjunctival space 2 2 2 2 2 2 2
236 Conjunctival space 2 2 +/2 2 +/2 2 2
606 Conjunctival space 2 2 2 2 2 2 2
686 Conjunctival space 2 + 2 2 2 2 2
Negative control
C1 Conjunctival space 2 2 2 2 2 2 2
C2 UT 2 2 2 2 2 2 2
C3 UT 2 2 2 2 2 2 2
*One negative control sheep (C1) and two untreated control sheep (C2, C3) were also necropsied.
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TCID50 dose of VMV via the trachea, positive snPCR
signals were obtained from the left conjunctiva and lung of
sheep 607c. In sheep 329c, a positive reaction was found in
the left conjunctival tissue (Table 2).
Several positive reactions were found in sheep infected via
the conjunctival space. Sheep 405 showed clear positive
reactions in the right third eyelid and right conjunctiva,
while sheep 301 was tested positive for proviral DNA in the
right third eyelid and the lung tissue (Fig. 1c). Very weak
equivocal reactions were discernible in sheep 271 and 200
when compared with control samples from two uninfected
animals analysed at the same time (not shown).
One of the two sheep receiving the 103 TCID50 virus dose
via the trachea (sheep 297c) gave a positive reaction in BAL
cells, but gave negative reactions in all other tissues
(Table 2). Sheep 361c gave negative reactions for all tissues
examined. Sheep 686 received virus via the conjunctival
space and gave a positive signal from the left conjunctiva
(Fig. 1c). Sheep 236 showed weak positive signals in the
right third eyelid and lung, while sheep 299 and 606 gave
negative signals in all tissues (Table 2).
Histopathological analysis of experimentally
infected sheep
To determine whether infection via the eyes resulted in
the development of lesions in the eyes, lung or MLN,
tissue samples taken at post-mortem were subjected to
histopathological analysis. Two sheep infected via the ocular
route were analysed from the group receiving 106 TCID50,
while all sheep receiving a 103 TCID50 dose were examined.
The degree of airways mononuclear cell infiltration, intersti-
tial pneumonia and lymph node follicular reactivity were
assessed and the lesions scored for severity. Representative
lesions are shown in Fig. 4. Samples from the three negative
control sheep showed no evidence of significant lesion
formation in lungs (Fig. 4) or ocular tissues (not shown).
Very mild follicular reactivity was present in the MLN of one
control animal. Two sheep that had been infected via the
conjunctival space with the 106 TCID50 virus dose had mild
lesions in the lungs (Fig. 4). This consisted of perivascular and
peribronchiolar infiltration by mononuclear cells and some
prominent bronchiole-associated lymphoid tissue. These
animals also had mild to moderately severe follicular
reactivity in the MLN (not shown).
Two animals receiving the 103 TCID50 virus dose via the
trachea showed evidence of perivascular and peribronch-
iolar infiltration by mononuclear cells, mild interstitial
lesion formation in lung tissue (Fig. 4), and mild to
moderate follicular reactivity in the MLN (not shown).
Three out of four animals infected via the conjunctival
space (sheep 299, 606 and 686) showed evidence of
perivascular and peribronchiolar infiltration with mono-
nuclear cells, mild focal interstitial lung lesions (Fig. 4),
and mild to moderate follicular reactivity (not shown).
Fig. 2. Detection of anti-VMV antibody by ELISA in sheep infected
with 106 TCID50 EV1 strain of virus. Sheep 405, 301, 271 and
200 received virus into the conjunctival space; sheep 329c and
607c received virus via the trachea. Optical density scale 0–2.0 for
all panels.
Fig. 3. Detection of anti-VMV antibody by ELISA in sheep infected
with 103 TCID50 EV1 strain. Sheep 236, 299, 606 and 686
received virus into the conjunctival space; sheep 361c and 297c
received virus via the trachea. Optical density scale 0–3.0 for
sheep 297c, and 0–0.3 for other panels.
VMV infection via the conjunctival space
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No differences in the degree of mononuclear cell infiltra-
tion or follicular reactivity were noted in the ocular tissues
of infected animals of either group of animals compared
with negative controls (not shown).
DISCUSSION
The main in vivo target cells for VMV are macrophages and
dendritic cells (Gendelman et al., 1986; Gorrell et al., 1992;
Brodie et al., 1995; Ryan et al., 2000), and any peripheral
tissue containing these cells could potentially be involved in
transmission and support replication and dissemination of
virus to the blood stream (Blacklaws et al., 2004; Peterhans
et al., 2004). In infected animals, it has been shown that the
bone marrow acts as a reservoir of infected cells and releases
infected monocytes into the blood stream for dissemination
to target tissues (Gendelman et al. 1985). Monocytes are
thought not to be permissive for virus replication for reasons
of immaturity, and it is only once these cells migrate into
tissues and differentiate into mature macrophages that they
are able to support productive infection (Narayan et al.,
1983; Gendelman et al., 1986). It is likely that further
activation of such infected macrophages by inflammatory
stimuli or possibly housekeeping activities is required for a
full virus replication cycle to take place (Small et al., 1989).
Following infection, animals tend to show an initial burst of
replication within a few weeks, followed by an extended
period of restricted replication or latency (Brahic et al., 1981;
Haase et al., 1977; Vigne et al., 1987; Staskus et al., 1991).
The mechanisms underlying such in vivo restriction are not
well understood, though interferon-like cytokines may be
involved (Zink & Narayan, 1989).
In the present study, we investigated whether sheep could
be infected via the conjunctival space by first determining
the presence of proviral DNA in blood by snPCR (Table 1).
Positive signals were obtained from all animals infected this
way in the first few weeks after infection. The proviral DNA
positivity fluctuated on a weekly basis, as did the apparent
strength of reactions. The pattern of positive reactions over
a period of 3–4 months was consistent with that described
in the literature for virus isolation after experimental
infection via other routes (Petursson et al., 1976; Larsen,
Hyllseth & Krogsrud, 1982a; Torsteinsdo´ttir et al., 1997;
Juste et al., 1998). The results showed clearly that animals
could be infected via the ocular route even with the
relatively low virus dose of 103 TCID50. In a study by
Torsteinsdo´ttir et al. (2003), it was shown that infection via
the tracheal route could be achieved by as little as 10
TCID50 of virus, while the minimum infectious dose for
nasal transmission was 106 TCID50. We recently showed
that the minimum infectious virus dose for tracheal tissue
in vitro was 105 TCID50, and that in vivo the tracheal route
was less efficient than direct virus exposure of the lung
(McNeilly et al., 2007). Thus, infection via the ocular route
appears to be intermediate in efficiency between the deep
lung and tissues of the upper respiratory tract.
To determine whether virus gene expression occurred
following infection via the conjunctival space, animals were
monitored for the appearance of anti-VMV antibodies by
ELISA. In the animals that received the higher virus dose,
seroconversion was evident a few weeks after infection in
sheep infected via the trachea and in three out of four
sheep infected via the conjunctival space. One of the sheep
infected via the ocular route showed delayed seroconver-
sion around 8 months post-infection. Delayed seroconver-
sion is an established feature of SRLV, SIV, FIV and HIV
infections (Houwers & van der Moelen, 1987; Cheevers
et al., 1988; Rimstad et al., 1993; Villinger et al., 1991;
Hopper et al., 1989; Horsburgh et al., 1989; Clerici et al.,
1991). Large variations in time to seroconversion have been
documented in VMV and CAEV infection, ranging from a
few weeks to several months to years, and are thought to be
due to the virus entering a state of restricted replication
(Brahic et al., 1981; Haase et al., 1977; Staskus et al., 1991).
It was, therefore, not unexpected for delayed seroconver-
sion to be observed in some of our experimentally infected
animals. The results showed that virus replication was
indeed productive and virus antigens had been recognized
by the host immune system. No correlation between the
number of positive PCR reactions and seroconversion was
evident, though measuring viral load using quantitative
real-time PCR methods might reveal a relationship.
In sheep that received the lower dose of virus, seroconver-
sion was observed in both animals that had been infected
via the trachea, but transiently in only one of the four
animals infected via the conjunctival space. These animals
were clearly virus-positive given their repeated positive
reaction in the snPCR assay of PBMCs. In other studies, we
have infected sheep with 103 TCID50 of the same EV1 virus
stock via the trachea and obtained evidence of infection
using the same PCR and ELISA (data not shown). Other
investigators have documented the efficiency of infection
via the trachea (Juste et al., 1998; Torsteinsdo´ttir et al.,
2003). The reason for the lack of seroconversion in three of
Fig. 4. Histological lesions in lung tissue at post-mortem following
infection with 106 TCID50 VMV via the conjunctival space (sheep
271, 200) or103 TCID50 VMV via the trachea (sheep 297c) or
conjunctival space (sheep 606, 686). The sheep identification
numbers are shown in each panel.
H. Niesalla and others
1334 Journal of General Virology 89
four animals receiving the lower dose of VMV via the eyes
in the present study is unclear. Persistently virus-positive
antibody-negative animals have been described by other
workers studying natural transmission, though these
tended to be only a small proportion of animals (De
Boer et al., 1979). In the latter study, some animals were
found to be virus-positive but antibody-negative over
several years of observation. It is possible that, had we
followed our animals for longer, they may have eventually
all seroconverted. As they stand, the results suggest that
infection via the ocular route with low doses of virus may
be an efficient way of generating PCR-positive, seronega-
tive animals.
Transient or intermittent antibody production following
experimental or natural infection has also been described
in several studies (de Andre´s et al., 2005; Mordasini et al.,
2006). The reasons underlying this phenomenon are
unknown, but are thought to be due to control of virus
replication by the immune response. It is likely that this is
due to cell-mediated responses, since neutralizing antibody
responses are slow to develop in SRLV infections (Larsen
et al., 1982b).
At post-mortem, evidence was obtained for proviral DNA in
one or more target tissues. Clear positive signals from the eye
and/or lung were obtained from two out of four sheep
infected via the conjunctival space with the higher virus dose,
and weak signals could be discerned from tissues of the other
two animals. When tissues from animals receiving the lower
virus dose were examined, one out of four animals infected
via the ocular route showed evidence of snPCR reactivity,
while the remaining three animals gave either equivocal or
negative signals. Detection of virus in tissues is often difficult,
given the restricted replication pattern in vivo and the long
protracted course of the infection. Hence, it would be
expected that there would be only low numbers of virus-
infected cells in target tissues, particularly after a relatively
short period of infection.
It is also clear that there is great variability in which the
organ system is affected in natural disease (Narayan &
Clements, 1989). Therefore, while it might be expected that
virus introduced into the lung via the trachea would
establish foci of infection in the lung tissue and draining
mediastinal lymph node, the low numbers of infected cells
likely to be present after this time period could render
detection uncertain. Thus, following introduction of virus
into the conjunctival space, it was not at all certain that any
of that input virus would reach the pulmonary system or
locate there preferentially. It is therefore significant that
positive signals from lung tissue were obtained following
ocular administration. The results indicate that virus exited
the eye tissues and gained access to the lungs. The high
proportion of samples found positive by PCR in the blood
of these animals is consistent with dissemination of virus
into the circulation from the conjunctival space.
In the case of the eyes, the physiological function of the
innate defences is to clear incoming pathogens quickly
through destruction and drainage into the nasal cavity.
Hence, unless a focus of infection in the eyes was
established, the expectation of detecting virus in the ocular
tissues more than a year after administration would be low.
However, positive signals were obtained from such tissues
in the animals receiving the higher virus dose. This could
indicate either that chronic infection was established in the
eye tissue from input virus in at least some of the animals,
or that virus dissemination to the blood stream and bone
marrow had taken place with subsequent infiltration of the
eye tissues by infected monocytes.
It is of interest to note that, despite the lack of
seroconversion in some animals, evidence for the presence
of early lesion formation was found in the lungs (mono-
nuclear cell infiltration and interstitial proliferation) and/
or draining mediastinal lymph node (follicular reactivity).
While these inflammatory lesions are not pathognomonic
for VMV infection, they are consistent with lesions
typically found in animals infected naturally or experi-
mentally with this virus (Petursson et al., 1976; Houwers
& van der Molen, 1987; Lujan et al., 1994), and were not
found in uninfected controls. It is generally thought that
the lesions in SRLV infections are immune-mediated
(Nathanson et al., 1976). Indeed, replication is enhanced
in the presence of activated CD4+ T-cells and reduced in
their absence (Eriksson et al., 1999). Similarly, vaccina-
tion studies using inactivated whole virus as antigen or
peptides from the gag precursor tend to increase virus
replication and/or enhance lesion formation (McGuire et
al., 1986; Nenci et al., 2007). It is possible that localized
immune responses in the lungs caused lesion devel-
opment without systemic humoral responses being
elevated. A PCR investigation of DNA isolated from
histological slides may help to determine the relationship
between the presence of virus and lesion formation in
these animals.
In summary, sheep can be infected via the conjunctival
space and induce lesions in the lung, though seroconver-
sion appears to be inefficient. The results suggest that
ocular contact with infected respiratory fluid in the field
may result in virus transmission.
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